136 related articles for article (PubMed ID: 19205108)
1. Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
Tallman M
Clin Adv Hematol Oncol; 2008 Nov; 6(11):3-5. PubMed ID: 19205108
[No Abstract] [Full Text] [Related]
2. New drugs in acute myeloid leukemia.
Estey E
Semin Oncol; 2008 Aug; 35(4):439-48. PubMed ID: 18692694
[TBL] [Abstract][Full Text] [Related]
3. New agents: great expectations not realized.
Lancet JE
Best Pract Res Clin Haematol; 2013 Sep; 26(3):269-74. PubMed ID: 24309529
[TBL] [Abstract][Full Text] [Related]
4. New agents for the treatment of AML recent study findings.
Gore SD
Clin Adv Hematol Oncol; 2008 Nov; 6(11):6-8. PubMed ID: 19205109
[No Abstract] [Full Text] [Related]
5. Future research directions for the treatment of AML.
Karp J
Clin Adv Hematol Oncol; 2008 Nov; 6(11):8-10. PubMed ID: 19205110
[No Abstract] [Full Text] [Related]
6. Clofarabine-based regimen as useful bridge therapy for allogeneic transplantation in myeloid blast crisis of Philadelphia-positive chronic myeloid leukemia resistant to imatinib and dasatinib.
Breccia M; Capria S; Iori AP; Foà R; Alimena G; Meloni G
Acta Haematol; 2010; 124(3):150-2. PubMed ID: 20938169
[No Abstract] [Full Text] [Related]
7. Recently approved therapies in acute myeloid leukemia: A complex treatment landscape.
Talati C; Sweet K
Leuk Res; 2018 Oct; 73():58-66. PubMed ID: 30223250
[TBL] [Abstract][Full Text] [Related]
8. Midostaurin in FLT3-mutated acute myeloid leukaemia.
Das M
Lancet Oncol; 2017 Aug; 18(8):e439. PubMed ID: 28669736
[No Abstract] [Full Text] [Related]
9. The prevalent predicament of relapsed acute myeloid leukemia.
Szer J
Hematology Am Soc Hematol Educ Program; 2012; 2012():43-8. PubMed ID: 23233559
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of c-Kit by tyrosine kinase inhibitors.
Galanis A; Levis M
Haematologica; 2015 Mar; 100(3):e77-9. PubMed ID: 25425690
[No Abstract] [Full Text] [Related]
11. 57th American Society of Hematology Annual Meeting.
Smith LL
Lancet Oncol; 2016 Feb; 17(2):142. PubMed ID: 26687594
[No Abstract] [Full Text] [Related]
12. Acute myeloid leukaemia: optimal management and recent developments.
Villela L; Bolaños-Meade J
Drugs; 2011 Aug; 71(12):1537-50. PubMed ID: 21861539
[TBL] [Abstract][Full Text] [Related]
13. Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity.
Robak T; Szmigielska-Kapłon A; Pluta A; Grzybowska-Izydorczyk O; Wolska A; Czemerska M; Wierzbowska A
Curr Med Chem; 2011; 18(5):638-66. PubMed ID: 21182488
[TBL] [Abstract][Full Text] [Related]
14. First new drug approval for AML in 15 years.
Sheridan C
Nat Biotechnol; 2017 Aug; 35(8):696-698. PubMed ID: 28787411
[No Abstract] [Full Text] [Related]
15. [Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents].
Takeshita A
Rinsho Ketsueki; 2003 Dec; 44(12):1133-43. PubMed ID: 14978929
[No Abstract] [Full Text] [Related]
16. Closing in on targeted therapy for acute myeloid leukaemia.
The Lancet Haematology
Lancet Haematol; 2019 Jan; 6(1):e1. PubMed ID: 30612709
[No Abstract] [Full Text] [Related]
17. [Novel medical treatment modalities in hematology].
Hasselbalch HC; Birgens H; Dufva IH; Dalseg AM; Brown Pde N; Jensen MK; Vangsted A
Ugeskr Laeger; 2008 Jun; 170(24):2115-9. PubMed ID: 18565291
[TBL] [Abstract][Full Text] [Related]
18. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
19. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.
Isidori A; Venditti A; Maurillo L; Buccisano F; Loscocco F; Manduzio P; Sparaventi G; Amadori S; Visani G
Expert Rev Hematol; 2013 Dec; 6(6):767-84. PubMed ID: 24219553
[TBL] [Abstract][Full Text] [Related]
20. Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin.
Chevallier P; Prebet T; Pigneux A; Hunault M; Delaunay J; Perry F; Lode L; Richebourg S; Blanchet O; Vey N; Ifrah N; Milpied N; Blaise D; Harousseau JL; Mohty M
Leukemia; 2010 Feb; 24(2):467-9. PubMed ID: 19847200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
